Mounjaro is an injectable medication that operates on a dual mechanism, targeting two hormones crucial for blood sugar regulation: GLP-1 and GIP
When tirzepatide is not worth the cost Tirzepatide is not worth the cost if you are not losing weight on it
[116] The tentative approval means that a scientific assessment of the generic drug was completed successfully, and that contracts and supply chains can be established, but that selling the drug would depend on intellectual property constraints
Targeting GLP-1 signaling represents a promising neuroprotective and potentially disease-modifying strategy for PD (Brauer et al
However, patients with conditions requiring fluid restriction (such as heart failure or advanced kidney disease) should follow their healthcare provider's specific guidance regarding fluid intake
Here we present a post hoc analysis of the large, multicenter, randomized, controlled Prediabetes Lifestyle Intervention Study (PLIS), demonstrating that prediabetes remission is achievable without weight loss or even weight gain, and that it also protects against incident T2D